Sunflower Pharmaceuticals Group Co Ltd (002737) — Capital Reinvestment Ratio
Sunflower Pharmaceuticals Group Co Ltd (002737) has a Capital Reinvestment Ratio of 0.06x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥247.91 Million) in capital expenditures (CN¥14.30 Million). See 002737 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sunflower Pharmaceuticals Group Co Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Sunflower Pharmaceuticals Group Co Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see market value of Sunflower Pharmaceuticals Group Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥574.97 Million | CN¥96.10 Million | ▲ +3.5% |
| 2023 | 0.16x | CN¥923.30 Million | CN¥149.16 Million | ▲ +108.2% |
| 2022 | 0.08x | CN¥1.97 Billion | CN¥152.90 Million | ▼ -43.3% |
| 2021 | 0.14x | CN¥865.23 Million | CN¥118.31 Million | ▼ -24.8% |
| 2020 | 0.18x | CN¥1.17 Billion | CN¥212.73 Million | ▼ -52.3% |
| 2019 | 0.38x | CN¥981.33 Million | CN¥374.24 Million | ▲ +3.0% |
| 2018 | 0.37x | CN¥866.21 Million | CN¥320.87 Million | ▲ +31.9% |
| 2017 | 0.28x | CN¥558.77 Million | CN¥156.88 Million | ▼ -39.9% |
| 2016 | 0.47x | CN¥341.23 Million | CN¥159.49 Million | ▼ -66.8% |
| 2015 | 1.41x | CN¥125.84 Million | CN¥177.32 Million | ▲ +187.4% |
| 2014 | 0.49x | CN¥403.23 Million | CN¥197.71 Million | ▼ -26.0% |
| 2013 | 0.66x | CN¥293.34 Million | CN¥194.44 Million | ▲ +89.9% |
| 2012 | 0.35x | CN¥327.31 Million | CN¥114.22 Million | ▼ -54.8% |
| 2011 | 0.77x | CN¥257.60 Million | CN¥199.10 Million | — |